As an SME with double-digit growth, Sidam can prove its capacity to do business in an industry strongly connected with research and innovation. A continuous product research and the flexibility that larger companies would be unable to guarantee have, for Sidam, revealed to be the most important business factors. The company is led by a woman, Annalisa Azzolini, who is also a shareholder of the company. • The company produces biomedical consumables with a particular focus on contrast fluid diagnostics. Sidam's innovations, highly specialized and being the result of research into its laboratories, are used by the most important hospitals in the world in the Radiology, Resuscitation and Subcutaneous Infusion Departments. • For Image Diagnostics Sidam supplies disposable medical devices, electro-medical equipment and an ultrasonic contrast injector. • Interventional Radiology deals with Vertebraeplasty, while for resuscitation departments, it delivers both medical devices and electro-medical equipments. • For Subcutaneous Infusion, Sidam produces vertical needle medical devices for pain therapy, thalassemia, immunoglobulin sets. • Among Sidam's jewels, the Nutrivent and the Optivent stand out. • It also has collaborations with MIUR (Ministry for Education,University and Research). • The company has a focus on internationalization: SIdam's work is in usage mainly abroad (about 80% of turnover is related to exports). • Sidam holds 14 patents currently operating in 19 countries. • It has 70 employees.